PRAMEF10 activators represent a diverse chemical class characterized by their ability to modulate gene expression through various epigenetic mechanisms. These activators can influence the cellular machinery responsible for the addition or removal of specific chemical groups, such as methyl or acetyl groups, on DNA and histone proteins, which in turn can alter the expression of PRAMEF10. This class includes inhibitors of DNA methyltransferases and histone deacetylases, among other enzyme targets. By inhibiting DNA methyltransferases, PRAMEF10 activators can promote the demethylation of DNA, which typically leads to a more open chromatin state and increased gene transcription. On the other hand, by inhibiting histone deacetylases, these activators can increase the acetylation levels of histones, also leading to an open chromatin configuration conducive to gene expression.
The chemical agents classified as PRAMEF10 activators can also engage with cellular signaling pathways that govern gene expression. They can interact with receptors that transduce signals to initiate transcription, thereby impacting the expression of a wide range of genes, including those that may be otherwise silent or expressed at low levels. Importantly, the activators in this class function at the molecular level to influence the epigenetic landscape of cells, which can result in changes to the transcriptional activity of genes like PRAMEF10. This modulation of gene expression is a fundamental process in cellular function and can have wide-ranging effects on the phenotype of a cell. Through such intricate molecular interactions, PRAMEF10 activators can play a significant role in the dynamic regulation of gene expression without altering the underlying DNA sequence.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor that could activate PRAMEF10 by leading to the demethylation and activation of gene expression, including genes that may be epigenetically silenced. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that could activate PRAMEF10 by causing chromatin to become more accessible for transcription, potentially increasing the expression of genes. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
An aldehyde dehydrogenase inhibitor, which has been shown to modulate epigenetic regulation and could activate PRAMEF10 by influencing the expression of proteins. | ||||||
6-Thioguanine | 154-42-7 | sc-205587 sc-205587A | 250 mg 500 mg | $42.00 $54.00 | 3 | |
A histone deacetylase inhibitor that could activate PRAMEF10 by leading to hyperacetylation of histones, potentially affecting gene expression patterns. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A metabolite of vitamin A that regulates gene expression through retinoid receptors and could activate PRAMEF10 by affecting the expression of related proteins. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A short-chain fatty acid and histone deacetylase inhibitor that could activate PRAMEF10 by altering gene expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A polyphenolic compound that could activate PRAMEF10 by modulating multiple cellular pathways through its effects on gene expression. | ||||||
Tazarotene | 118292-40-3 | sc-220193 | 10 mg | $103.00 | ||
A synthetic retinoid that could activate PRAMEF10 by affecting gene expression through retinoid receptors. | ||||||